PAMELA DRYDEN: Open Payments
NPI 1235991076 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $277 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $52 |
| Genmab U.S., Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: SARCLISA, Epkinly, OJJAARA, LYNPARZA.
Industry payments across CO — which companies pay providers there.
